<DOC>
	<DOCNO>NCT02459262</DOCNO>
	<brief_summary>Part A : The primary objective evaluate safety tolerability potential vaccine Group B streptococcus . Part B : To evaluate long term safety profile GBS-NN vaccine one year follow first dose .</brief_summary>
	<brief_title>Safety Immunogenicity Group B Streptococcus Vaccine Non-pregnant Women 18-40 Years Age .</brief_title>
	<detailed_description>Part A : Subjects receive 2 dos vaccine , GBS-NN , follow 12 week first dose vaccine . The following safety endpoint evaluate support objective : local systemic reactogenicity ; adverse event ; laboratory test ; urinalysis ; vital sign ; 12-Lead ECG parameter ; physical examination . In addition hereto , immunological parameter evaluate . Part B : Subjects receive one 2 dos GBS-NN , follow 12 month first dose vaccine . The following safety endpoint evaluate support objective : local systemic reactogenicity ; adverse event ; laboratory test ; urinalysis ; vital sign ; 12-Lead ECG parameter ; physical examination . In addition hereto , immunological parameter evaluate .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aluminum Hydroxide</mesh_term>
	<criteria>1 . Healthy adult female volunteer ( determined medical history , physical examination , laboratory test value , vital sign electrocardiograms [ ECGs ] screen ) age 18 40 year . 2 . Body mass index ( BMI ) ≥ 18 ≤ 30 kg/m2 . 3 . Volunteers weight ≥ 50kg ≤100kg screening . 4 . Able voluntarily provide write informed consent participate study . 5 . Must understand purpose risk study agree follow restriction schedule procedure define protocol . 6 . Volunteers must premenopausal . Volunteers hysterectomy premenopausal status confirm FSH oestradiol test . 7 . Females childbearing potential must negative pregnancy test screening ( β HCG ) prior dose must willing use adequate highly effective method contraception least Day 85 study . A highly effective method birth control define one result low failure rate ( i.e . le 1 % per year ) use consistently correctly sterilisation , implant , injectables , combine oral contraceptive , IUDs ( Intrauterine Device ) , condom , occlusive cap ( cervical/vault cap ) spermicidal foam/gel/ film/cream/suppository . True sexual abstinence acceptable line prefer usual lifestyle volunteer ( periodic abstinence e.g . calendar , ovulation , symptothermal , postovulation method , declaration abstinence duration trial , withdrawal acceptable method contraception ) 8 . In Part A : Volunteers must nonsmoker least 3 month prior first studyvaccine administration . In Part B : Volunteers may light smoker i.e . maximum 5 cigarette per day nicotine equivalent . 9 . Must willing consent data enter The Over Volunteering Prevention System ( TOPS ) . 10 . The volunteer 's primary care physician confirm within last 12 month nothing medical history would preclude enrolment clinical trial . 1 . Volunteers history presence significant cardiovascular disease , pulmonary , hepatic , gallbladder biliary tract , renal , haematological , gastrointestinal , endocrine , immunologic , dermatological , neurological , psychiatric , autoimmune disease current infection . 2 . Pregnant lactating female . 3 . Laboratory value screen deem clinically significant , unless agree advance Sponsor 's Responsible Medic Principal Investigator . 4 . Current history drug alcohol abuse , positive alcohol breath test prior first dose . 5 . Positive human immunodeficiency virus ( HIV ) , hepatitis B hepatitis C. 6 . Participation clinical drug study 90 day precede initial dose study . 7 . Any significant illness 4 week precede checkin study ( Day 1 ) . 8 . Volunteers history severe allergic reaction previous vaccination . 9 . Volunteers receive vaccine within 30 day screen , plan receive vaccine Day 85 study . 10 . Volunteers receive immunosuppressive therapy ( e.g . systemic steroid , cancer therapy , methotrexate , azathioprine ) 6 month prior screen , antibiotic within 10 day receive first dose take shortterm medication include overthecounter preparation , vitamin , herbal and/or mineral supplement within 7 day first dose . Chronic medication antihypertensive , bronchodilator , oral contraceptive statin affect immune system , permit allow continue study discretion Investigator . Paracetamol permit treatment headache symptom . 11 . Volunteers tattoo propose site vaccine administration . 12 . Donation blood blood product within 90 day prior vaccine administration . 13 . Volunteers , opinion Investigator , unsuitable participation study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>